Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma

By  

Current Cancer Drug Targets, Vol. 10, Iss. 3, 2010-05 ,pp. : 332-342

Bentham Science Publishers

Access to resources Recommend Favorite

Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells

By Rzeski Wojciech   Stepulak Andrzej   Szymański Marek   Sifringer Marco   Kaczor Józef   Wejksza Katarzyna   Zdzisińska Barbara   Kandefer-Szerszeń Martyna  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 1, 2006-10 ,pp. : 11-20

Springer Publishing Company

Access to resources Recommend Favorite

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1284-1292

Bentham Science Publishers

Access to resources Recommend Favorite

The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6155-6168

Bentham Science Publishers

Access to resources Recommend Favorite

Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 833-840

Bentham Science Publishers

Access to resources Recommend Favorite